Cash & equivalents increased 25.2%
Cash & equivalents changed +25.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +25.2% from the comparable as-filed period.
Gross margin changed -302 basis points from the comparable as-filed period.
Gross profit changed -10.2% from the comparable as-filed period.
Inventory changed -21.3% from the comparable as-filed period.
Net income changed -55.2% from the comparable as-filed period.
Operating income changed -160.9% from the comparable as-filed period.
Operating margin changed -401 basis points from the comparable as-filed period.
Research & development changed -15.0% from the comparable as-filed period.
Revenue changed -4.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.